Published in Am J Epidemiol on November 01, 2000
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol (2004) 8.99
U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains. J Virol (2003) 2.64
GenGIS: A geospatial information system for genomic data. Genome Res (2009) 2.10
Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol (2001) 1.51
Characterization of partial and near full-length genomes of HIV-1 strains sampled from recently infected individuals in São Paulo, Brazil. PLoS One (2011) 1.02
A new NMR solution structure of the SL1 HIV-1Lai loop-loop dimer. Nucleic Acids Res (2006) 1.01
Genetic analysis of HIV-1 subtypes in Nairobi, Kenya. PLoS One (2008) 1.00
Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virol J (2013) 0.99
Efficient detection of contagious outbreaks in massive metropolitan encounter networks. Sci Rep (2014) 0.86
Segregation of human immunodeficiency virus type 1 subtypes by risk factor in Australia. J Clin Microbiol (2003) 0.80
Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors. PLoS One (2016) 0.79
Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe. PLoS One (2015) 0.78
Multiple introductions and onward transmission of non-pandemic HIV-1 subtype B strains in North America and Europe. Sci Rep (2016) 0.75
Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia. Infect Genet Evol (2016) 0.75
Genomic Diversity of Human Immunodeficiency Viruses. Med J Armed Forces India (2011) 0.75
Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol (1992) 4.39
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J Virol (1997) 2.32
Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology (1991) 1.85
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains. AIDS (2001) 1.42
Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. J Gen Virol (1993) 1.31
A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J Virol (1995) 1.28
Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O. J Clin Microbiol (2001) 1.26
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Res Hum Retroviruses (2001) 1.22
Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. J Clin Microbiol (1999) 1.20
Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol (1995) 1.14
HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals. AIDS (1992) 1.07
Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1. J Med Virol (1990) 1.05
Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individuals. J Gen Virol (1992) 1.03
Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals. J Acquir Immune Defic Syndr (1990) 0.99
A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism. J Virol (1997) 0.99
Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine (1996) 0.94
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals. J Acquir Immune Defic Syndr (1991) 0.92
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses (2000) 0.92
Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIB. Lancet (1990) 0.90
Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient. AIDS (2000) 0.88
Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression. AIDS (1989) 0.88
Monoclonal antibodies to immunodominant and neutralizing domains of the envelope surface protein of feline immunodeficiency virus. J Gen Virol (1994) 0.83
Competitive reverse transcription-polymerase chain reaction for quantitation of feline immunodeficiency virus. J Virol Methods (1995) 0.82
Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo. J Med Virol (1995) 0.81
Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus. J Gen Virol (1999) 0.81
Modulation of the human papillomavirus type 16 induced transformation and transcription by deletion of loci on the short arm of human chromosome 11 can be mimicked by SV40 small t. Virology (1992) 0.80
Evaluation of subunit vaccines against feline immunodeficiency virus infection. Vaccine (1996) 0.80
Expression of feline immunodeficiency virus gag and env precursor proteins in Spodoptera frugiperda cells and their use in immunodiagnosis. J Clin Microbiol (1993) 0.79
Seroconversion to HIV-1 rev- and tat-gene-encoded proteins. AIDS (1989) 0.77
Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection. Vaccine (1998) 0.77
The early enhancer-promoter of BKV and host range for transformation. Intervirology (1987) 0.77
HIV1 3' ORF is open in pathological tissue and accelerates viral replication in primary lymphocytes. Res Virol (1992) 0.77
Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivo. J Clin Microbiol (1999) 0.76
Vaccination against feline immunodeficiency virus using fixed infected cells. Vet Immunol Immunopathol (1995) 0.76
The feline immunodeficiency virus envelope protein precursor: functional analysis of a leader deletion mutant. Vet Microbiol (1999) 0.75
Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus. J Gen Virol (1997) 0.75
Epidemiology of HIV-1 and emerging problems. Int J Antimicrob Agents (2000) 0.75
Seroconversion to HIV-1 negative regulation factor. Lancet (1988) 0.75